Almeda Ventures Limited Partnership is a venture capital firm specializing in seed, start up, early venture and middle market investments. The firm seeks to invest in health technology with focus on public R&D partnership, medical devices, digital health and bio-convergence; life sciences research and development company. It prefers to invest in Israel, USA and Europe. Almeda Ventures Limited Partnership was founded in 2020 and is based in Tel Aviv, Israel.

Almeda Ventures Limited Partnership

Almeda Ventures is a HealthTech focused public R&D partnership. The company invests globally in medical devices, digital health, and bio-convergence. Almeda Ventures supports portfolio companies with expertise, network connections, and resources to drive success in the medical device and digital health sectors.

Almeda Ventures

Almeda Ventures - 
The Next Generation of HealthTech Investments
Investing in Medical Device, Digital Health and Bio-Convergence

Initial responses to ArtiFascia are exciting!

Great testimonial below!
Dr. Michael Groff has been the first user of ArtiFascia, our dural repair graft, which was launched earlier this year. His words say everything 💡 
ArtiFascia has been used in dozens of surgeries successfully, showing exceptional versatility of applications and excellent clinical results.
#neurosurgery #artifascia
https://lnkd.in/dtCWXiEV

Our CEO, Sharon Ravid, was recently featured in an insightful interview with TheMarker, hosted by Gadi Sukenik.
Sharon discussed the innovation behind our product, in2, and how it uses EMS technology to manage Premature Ejaculation.

This interview sheds light on our commitment to advancing sexual health and providing solutions that help couples lead fulfilling intimate lives.

We are dedicated to normalizing conversations around sexual health and addressing intimate issues between couples openly and transparently.

Watch the full video interview on The Marker. 

#TheMarker #Interview #VirilityMedical #in2 #SexualHealth #Innovation #PrematureEjaculation #EMS #MedicalDevice

What a great auidence! thank you for inviting me 🫠

#WCB2024 thank you for everyone to attended our breakfast symposium this morning. Stop by booth #10 to schedule your live virtual case observation. #prostatecancer #rectalspacer #gamechanger

The AXIUS articulating needle driver allows surgeons to precisely follow the needle’s curve through dense fibrous tissue, such as Cooper’s ligament, as well as thin delicate tissue, like peritoneum. 

Accurate needle placement and the ability to drive the needle both towards and away from yourself helps to simplify the challenging suturing in TAPP inguinal hernia repair.

#hernia #herniasurgery #advancedlaparoscopy #innovation #medicaldevices #surgery #minimallyinvasivesurgery #roboticsurgery

לומן, חברת פרוטפוליו של אלמדה. קריאה נעימה

Well done and good luck to Sensi.AI and its amazing team for an impressive closing of its B round!

Almeda Ventures (#LSIEurope24 Investor) is a venture capital firm focused on investments in early-stage medical technology and digital health startups.

Almeda Ventures takes a hands-on approach to its investments, often working closely with its portfolio companies to provide strategic guidance, operational support, and access to a robust network of industry experts and resources. The firm seeks to add value beyond capital by leveraging its deep industry expertise and connections.

They specifically invest in three key areas:
• Medical devices
• Digital health
• Bio-convergence

Almeda is based in Israel and invests globally. Their portfolio includes companies like:
• FlexDex Surgical (James Geiger)
• Nurami Medical (#LSIAlumni - Nora Nseir)
• in2 By Virility Medical (Sharon Ravid)
• among others

We’re thrilled to welcome Dr. Irit Yaniv, Founding Partner and CEO at Almeda Ventures to LSI Europe ‘24 this September 16-20th in Sintra, Portugal.

Want to see what other investors are joining us at LSI Europe ‘24? Head over to our website to see a preview.

	Dec '20	Dec '21	Dec '22	Dec '23
revenue		4.96M -	3.19M 35.65%	-292K 109.16%
cost of revenue		127.23K -	193.39K 52.00%	36K 81.38%
gross profit		4.83M -	3.00M 37.96%	-328K 110.95%
selling and marketing expenses
general and administrative expenses	2.01M -	4.72M 134.86%	5.24M 11.00%	1.30M 75.17%
selling general and administrative expenses	2.01M -	4.72M 134.86%	5.24M 11.00%	1.30M 75.17%
research and development expenses
other expenses
cost and expenses	1.53M -	4.72M 209.47%	5.64M 19.41%	1.33M 76.38%
operating expenses	1.53M -	4.60M 201.13%	5.45M 18.51%	1.30M 76.21%
interest expense
ebitda	495.89K -	108.61K 78.10%	-2.24M 2,162.16%	-1.55M 30.71%
operating income	-2.01M -	105.51K 105.25%	-2.25M 2,229.47%	-1.63M 27.45%
depreciation and amortization	2.01M -	3.10K 99.85%	7.03K 126.62%	78K 1,009.22%
total other income expenses net	495.89K -	55.86K 88.74%	-7.03K 112.59%	48K 782.50%
income before tax	-1.52M -	161.37K 110.65%	-2.25M 1,496.71%	-1.58M 29.81%
income tax expense	495.89K -		-3.52K -
net income	-1.52M -	161.37K 110.65%	-2.25M 1,494.53%	-1.58M 29.70%
weighted average shs out	2.79M -	17.33M 521.46%	12.37M 28.63%	12.17M 1.62%
weighted average shs out dil	2.79M -	18.69M 570.10%	12.37M 33.82%	12.37M 0%
eps	-0.54 -	0.01 101.72%	-0.18 2,035.48%	-0.13 27.78%
epsdiluted	-0.54 -	0.01 101.59%	-0.18 2,193.02%	-0.13 27.78%

AMDA

COM:ALMEDAVENTURES

Almeda Ventures

Last Close

159.50

25/11 08:15

Market Cap

22.27M

Beta: -

Volume Today

100

Avg: -

Preview